Valuation Amgen Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2025-01-24 pm EST			5-day change	1st Jan Change
275.42 ^USD	-0.89%		+1.22%	+5.67%

Jan. 24	Janux Therapeutics Promotes Zachariah McIver to Chief Medical Officer	MT
Jan. 24	Janux Therapeutics, Inc. Promotes Zachariah McIver to Chief Medical Officer	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	143,240	133,852	126,718	140,139	154,142	148,047	148,047	-
Change	-	-6.55%	-5.33%	10.59%	9.99%	-3.95%	0%	-
Enterprise Value (EV) ¹	164,232	156,191	151,990	169,779	207,811	197,510	191,892	186,293
Change	-	-4.9%	-2.69%	11.7%	22.4%	-4.96%	-2.84%	-2.92%
P/E ratio	18.7x	18.7x	21.9x	21.7x	23.1x	30.2x	21.5x	20.2x
PBR	14.7x	14.1x	18.7x	38.3x	24.7x	22.8x	18.7x	15x
PEG	-	-4.23x	-1.3x	1.2x	7.36x	-1.1x	0.5x	3.3x
Capitalization / Revenue	6.13x	5.26x	4.88x	5.32x	5.47x	4.46x	4.3x	4.22x
EV / Revenue	7.03x	6.14x	5.85x	6.45x	7.37x	5.95x	5.58x	5.31x
EV / EBITDA	12.3x	9.8x	9.61x	10.5x	11.9x	10.5x	10.1x	9.75x
EV / EBIT	14.7x	12.7x	12.2x	13.3x	15.5x	13.3x	12.3x	11.9x
EV / FCF	19.2x	15.8x	18.1x	19.3x	28.2x	16.3x	15.7x	14.2x
FCF Yield	5.2%	6.33%	5.51%	5.17%	3.54%	6.14%	6.37%	7.05%
Dividend per Share ²	5.8	6.4	7.04	7.76	8.52	9.035	9.638	10.18
Rate of return	2.41%	2.78%	3.13%	2.95%	2.96%	3.28%	3.5%	3.7%
EPS ²	12.88	12.31	10.28	12.11	12.49	9.134	12.83	13.62
Distribution rate	45%	52%	68.5%	64.1%	68.2%	98.9%	75.1%	74.8%
Net sales ¹	23,362	25,424	25,979	26,323	28,190	33,175	34,407	35,067
EBITDA ¹	13,363	15,935	15,822	16,178	17,470	18,850	19,044	19,102
EBIT ¹	11,157	12,334	12,424	12,761	13,399	14,819	15,571	15,664
Net income ¹	7,842	7,264	5,893	6,552	6,717	4,983	6,259	6,979
Net Debt ¹	20,992	22,339	25,272	29,640	53,669	49,463	43,844	38,245
Reference price ²	241.07	229.92	224.97	262.64	288.02	275.42	275.42	275.42
Nbr of stocks (in thousands)	594,184	582,169	563,266	533,579	535,178	537,533	537,533	-
Announcement Date	1/30/20	2/2/21	2/7/22	1/31/23	2/6/24	-	-	-

¹USD in Million²USD

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield	Capi. ($)
AMGEN INC.	30.42x	5.99x	10.55x	+3.25%	149B
ELI LILLY AND COMPANY	61.02x	15.74x	44x	+0.68%	690B
NOVO NORDISK A/S	25.98x	9.22x	18.6x	+1.88%	360B
JOHNSON & JOHNSON	21.18x	4.1x	11.98x	+3.25%	353B
ABBVIE INC.	37.66x	6.42x	14.25x	+3.65%	302B
MERCK & CO., INC.	13.72x	4.17x	9.96x	+3.16%	244B
ROCHE HOLDING AG	16.71x	3.89x	10.16x	+3.59%	243B
ASTRAZENECA PLC	25.56x	4.39x	13.83x	+2.28%	211B
NOVARTIS AG	17.87x	4.22x	10.75x	+3.78%	199B
PFIZER, INC.	15.05x	3.3x	8.38x	+6.30%	150B
Average	26.52x	6.14x	15.25x	+3.18%	290.15B
Weighted average by Cap.	32.22x	7.82x	20.12x	+2.65%